Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 5 5588 05213 61530 78830 788-
Entreprise Value (EV)1 5 6858 17813 72331 04930 95230 690
P/E ratio 34,5x38,7x58,1x89,7x73,1x63,0x
Yield 0,76%0,65%0,46%0,28%0,35%0,40%
Capitalization / Revenue 5,14x6,64x9,45x16,4x13,6x12,0x
EV / Revenue 5,26x6,75x9,53x16,5x13,6x11,9x
EV / EBITDA 19,3x23,9x32,6x53,3x43,7x37,4x
Price to Book 6,37x7,77x11,7x20,7x16,6x13,7x
Nbr of stocks (in thousands) 92 18092 18092 18092 18092 180-
Reference price (EUR) 60,387,4148334334334
Last update 01/31/201801/29/201901/28/202001/04/202101/04/202101/04/2021
1 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 1 0811 2121 4411 8772 2702 570
EBITDA1 295342422583708821
Operating profit (EBIT)1 222300332494602699
Operating Margin 20,5%24,8%23,0%26,3%26,5%27,2%
Pre-Tax Profit (EBT)1 221285318467566656
Net income1 161208235342417469
Net margin 14,9%17,2%16,3%18,2%18,4%18,3%
EPS2 1,752,262,543,724,575,30
Dividend per Share2 0,460,570,680,931,161,34
Last update 01/31/201801/29/201901/28/202001/04/202101/04/202101/04/2021
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 127126108261164-
Net Cash position1 -----98,0
Leverage (Debt / EBITDA) 0,43x0,37x0,26x0,45x0,23x-0,12x
Free Cash Flow1 47,950,7174155260341
ROE (Net Profit / Equities) 19,8%21,8%21,4%25,5%24,9%23,4%
Shareholders' equity1 8159541 0981 3381 6762 007
ROA (Net Profit / Asset) 12,4%14,0%13,8%17,7%18,3%17,5%
Assets1 1 3001 4881 6961 9322 2762 688
Book Value Per Share2 9,4611,212,616,120,124,4
Cash Flow per Share2 1,902,473,362,994,815,66
Capex1 127177136158207229
Capex / Sales 11,7%14,6%9,44%8,41%9,14%8,93%
Last update 01/31/201801/29/201901/28/202001/22/202101/22/202101/22/2021
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (EUR)
30 788 183 460
Capitalization (USD)
37 446 100 049
Net sales (EUR)
1 440 600 000
Net sales (USD)
1 752 504 306
Number of employees
6 979
Sales / Employee (EUR)
206 419
Sales / Employee (USD)
251 111
Free-Float
25,7%
Free-Float capitalization (EUR)
7 912 553 854
Free-Float capitalization (USD)
9 623 636 407
Avg. Exchange 20 sessions (EUR)
19 010 545
Avg. Exchange 20 sessions (USD)
23 126 518
Average Daily Capital Traded
0,06%
EPS & Dividend